On September 19, 2023 Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, reported that Dr. Mahesh Patel, President and Chief Executive Officer, will present and meet with investors at the 2023 Cantor Fitzgerald Global Heathcare Conference to take place September 26th to September 28th in New York City (Press release, Lipocine, SEP 19, 2023, View Source [SID1234635247]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details

Format: Panel Presentation — Lipocine Inc. & Fennec Pharmaceuticals Inc.
Date/ Time: Wednesday, September 27, 3:00-3:30 PM ET
Webcast Link: View Source
Location: InterContinental NY Barclay Hotel (Track 4)

To request a 1×1 meeting with Lipocine management, please contact your representative at Cantor Fitzgerald.